COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,696 Articles (22,913 medRxiv, 8,783 bioRxiv)

Most recent first Previous |  Page 510: Articles 5091-5100  | Next

A single C-terminal residue controls SARS-CoV-2 spike trafficking and virion assembly
Dey, D., Qing, E., He, Y., Chen, Y., Jennings, B., Cohn, W., Singh, S., Gakhar, L., Schnicker, N. J., Pierce, B. G., Whitelegge, J. P., Doray, B., Orban, J. P., Gallagher, T., Hasan, S. S.
10.1101/2023.03.09.531992 — Posted: 2023-03-10
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
De Cae, S., Van Molle, I., van Schie, L., Shoemaker, S. R., Deckers, J., Debeuf, N., Lameire, S., Nerinckx, W., Roose, K., Fijalkowska, D., Devos, S., Desmet, A.-S., Zavala Marchan, J. C., Venneman, T., Ghassabeh, G. H., Sedeyn, K., Ballegeer, M., Vanheerswynghels, M., De Wolf, C., Demol, H., Vanhaverbeke, P., Lonigro, C., Bockstal, V., Rinaldi, M., Abdelnabi, R., Neyts, J., Marqusee, S., Lambrecht, B. N., Callewaert, N., Remaut, H., Saelens, X., Schepens, B.
10.1101/2023.03.10.531533 — Posted: 2023-03-10
SARS-CoV-2 protein structure and sequence mutations: evolutionary analysis and effects on virus variants SARS-CoV-2 protein structure and sequence mutations:
Ugo, L., Barbara, P., Giuseppe, T., Guzzi, P. H., Pierangelo, V.
10.1101/2023.03.09.531961 — Posted: 2023-03-10
Impaired potency of neutralizing antibodies against cell-cell fusion mediated by SARS-CoV-2
Wang, Q., Yeh, A. Y., Guo, Y., Yu, J., Ho, D. D., Liu, L.
10.1101/2023.03.09.531948 — Posted: 2023-03-10
Molecular pathology of acute respiratory distress syndrome, mechanical ventilation and abnormal coagulation in severe COVID-19
Soule, A., Ma, W. R., Liu, K. Y., Allard, C., Qureshi, S., Tremblay, K., Emad, A., Rousseau, S.
10.1101/2023.03.09.23286797 — Posted: 2023-03-10
Index Cases First Identified by Nasal-Swab Rapid COVID-19 Tests Had More Transmission to Household Contacts Than Cases Identified by Other Test Types
Ji, J., Viloria Winnett, A., Shelby, N., Reyes, J. A., Schlenker, N. W., Davich, H., Caldera, S., Tognazzini, C., Goh, Y.-Y., Feaster, M., Ismagilov, R. F.
10.1101/2023.03.09.23286855 — Posted: 2023-03-10
Spatio-temporal distributions of COVID-19 vaccine doses uptake in the Netherlands: A Bayesian ecological modelling analysis
Wang, H., Varol, T., Gultzow, T., Zimmermann, H. M. L., Ruiter, R. A. C., Jonas, K. J.
10.1101/2023.03.09.23287033 — Posted: 2023-03-10
Cause of Death by Race and Ethnicity in Minnesota Before and During the COVID-19 Pandemic, 2019-2020
Blake, M., Marka, N., Steer, C., Ravdin, J.
10.1101/2023.03.09.23287048 — Posted: 2023-03-10
Recent evolutionary origin and localized diversity hotspots of mammalian coronaviruses
Maestri, R., Perez-Lamarque, B., Zhukova, A., Morlon, H.
10.1101/2023.03.09.531875 — Posted: 2023-03-09
Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies
Grant, M. D., Bentley, K., Fielding, C. A., Hatfield, K. M., Ings, D. P., Harnum, D., Wang, E., Stanton, R., Holder, K. A.
10.1101/2023.03.09.531709 — Posted: 2023-03-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).